| Stage | MATV | % of rev | ECVT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $532M | 100.00% | $250M | 100.00% | MATV ×2.13 |
| Gross profit | $113M | 21.31% | $50M | 19.94% | MATV +1.4pp |
| Operating income | $35M | 6.64% | $19M | 7.75% | ECVT +1.1pp |
| Pre-tax income | $7M | 1.28% | $15M | 5.96% | ECVT +4.7pp |
| Net income | $4M | 0.68% | $8M | 3.15% | ECVT +2.5pp |
| Stage | MATV | ECVT | Gap · A − B |
|---|---|---|---|
| Revenue | $532M100.00% | $250M100.00% | MATV ×2.13 |
| Gross profit | 21.31%$113M | 19.94%$50M | MATV +1.4pp |
| Operating income | 6.64%$35M | 7.75%$19M | ECVT +1.1pp |
| Pre-tax income | 1.28%$7M | 5.96%$15M | ECVT +4.7pp |
| Net income |
| 0.68%$4M |
| 3.15%$8M |
| ECVT +2.5pp |
None
No disclosed counterparties: MATV.